Item 1A. Risk Factors
2K characters. Original on sec.gov ·
Item 1A. Risk Factors
There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(dollars in thousands, except per share data)
We had two share repurchase authorizations outstanding during the quarter ended March 31, 2023. On May 4, 2022 and August 3, 2022, we publicly announced that our Board of Directors authorized the repurchase of our outstanding common stock in one or more open market and/or privately negotiated transactions, up to an aggregate of $500,000 per authorization. The repurchase authorizations do not have expiration dates. We repurchased the following shares of our common stock during the first quarter of 2023:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| January 1 - 31, 2023 | — | $ | — | — | $ | 507,685 | ||||||||||||||||||||
| February 1 - 28, 2023 | 9,965 | $ | 5,104.63 | 9,965 | $ | 456,817 | ||||||||||||||||||||
| March 1 - 31, 2023 | 11,209 | $ | 5,279.75 | 11,209 | $ | 397,637 | ||||||||||||||||||||
| Total (1) | 21,174 | $ | 5,197.33 | 21,174 |
(1) Of the 21,174 shares repurchased during the quarter ended March 31, 2023, 1,514 outstanding shares were repurchased under the May authorization, and the remaining 19,660 outstanding shares were repurchased under the August authorization. The May authorization has been fully utilized as of March 31, 2023.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits